The Week

Centrus Energy (LEU) fell 12.41% this week to close at $152.31, underperforming the S&P 500 by about 11.61 percentage points as the benchmark slipped 0.8%. The tape was a textbook fade: Tuesday opened at $176.49 and hit an intraday high of $191.205, but Thursday and Friday saw consecutive declines, with Friday touching the week’s low of $152.12. Weekly amplitude ran to 22.15%, and average daily volume of roughly 8.39m shares sat about 25.66% above the median.

Key Events

The week’s story was expansion signals colliding with dilution pressure. On Tuesday, the stock gained amid renewed interest in nuclear names. Wednesday brought a sharp intraday gain of 9.06% on news of a major supply contract with X-energy and an expansion of low-enriched uranium operations; the same day, Centrus announced a long-term partnership with Radiant for a multi-year HALEU supply to Kaleidos microreactors. But after the close on Wednesday, the company disclosed a proposed $500m underwritten public offering of Class A common stock and warrants. Dilution concerns took over on Thursday and Friday, with the stock down as much as 8.06% intraday on Friday, and related 424B5 filings and final prospectus documents landed over the same period.

Analyst Ratings

As of 11 September, 19 covering institutions rate the stock: 12 give it a buy or overweight, 7 a hold, and none an underweight or sell. The consensus recommendation is buy, with a consensus target of $247.39824, roughly 62.43% above spot. Target prices range from $168.77 to $340.00, a wide spread that points to real divergence among analysts. The stock ranks second out of 15 within its coal and consumable fuels industry group.

The Week Ahead

With offering terms now set, the market will focus on final pricing and the actual dilution impact. On the macro side, the US releases the Empire State manufacturing index, retail sales and import price data next week, which may keep driving risk appetite across this high-volatility name.

In Short

Centrus Energy spent the week pulled in two directions: supply contracts offered an upward pull, while the $500m stock-and-warrants offering triggered a sell-off, and the stock finished sharply lower. The consensus rating is buy with meaningful upside to target, but valuation is stretched at roughly 62.66x P/E and 3.59x P/B, and the latest session shows net selling from retail and medium-sized flows. The key question now is how the market absorbs the new shares once pricing lands, and whether macro data gives risk assets a cushion.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.